CEBPA and acute myeloid leukemia: As the majority of patients with CEBPA mutant AML harbor combined N- and C- terminal CEBPA mutations, it is possible that the N-terminal CEBPA mutation provides sufficient residual myeloid differentiation potential to enter the myeloid lineage and initiate AML.